Literature DB >> 33606145

Dihydroartemisinin prevents palmitate-induced β-cell apoptosis.

Zhiyong Wang1, Yan Hao1, Haibing Yu2, Pei Wei3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33606145     DOI： 10.1007/s10495-021-01660-6

Source DB:  PubMed          Journal:  Apoptosis        ISSN： 1360-8185            Impact factor:   4.677


× No keyword cloud information.
  11 in total

1.  Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function.

Authors:  Ping Lu; Fu-Chuang Zhang; Shu-Wen Qian; Xi Li; Zhao-Meng Cui; Yong-Jun Dang; Qi-Qun Tang
Journal:  Cell Res       Date:  2016-09-16       Impact factor: 25.617

2.  Artemisinin: A Promising Adjunct for Cancer Therapy.

Authors:  Yamna Waseem; Choudhary A Hasan; Furqan Ahmed
Journal:  Cureus       Date:  2018-11-23

Review 3.  Toxicity of the antimalarial artemisinin and its dervatives.

Authors:  Thomas Efferth; Bernd Kaina
Journal:  Crit Rev Toxicol       Date:  2010-05       Impact factor: 5.635

Review 4.  Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

5.  Effect of leaf digestion and artemisinin solubility for use in oral consumption of dried Artemisia annua leaves to treat malaria.

Authors:  Matthew R Desrosiers; Pamela J Weathers
Journal:  J Ethnopharmacol       Date:  2016-06-20       Impact factor: 4.360

Review 6.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

7.  Artemisinin and dihydroartemisinin promote β-cell apoptosis induced by palmitate via enhancing ER stress.

Authors:  Ke Chen; Hu Hua; Ziyang Zhu; Tong Wu; Zhanjun Jia; Qianqi Liu
Journal:  Apoptosis       Date:  2020-04       Impact factor: 4.677

8.  Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines.

Authors:  Weiwei Jiang; Yanyan Cen; Yi Song; Pan Li; Rongxin Qin; Chao Liu; Yibo Zhao; Jiang Zheng; Hong Zhou
Journal:  Phytomedicine       Date:  2016-06-06       Impact factor: 5.340

9.  Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.

Authors:  Borimas Hanboonkunupakarn; Elizabeth A Ashley; Podjanee Jittamala; Joel Tarning; Sasithon Pukrittayakamee; Warunee Hanpithakpong; Palang Chotsiri; Thanaporn Wattanakul; Salwaluk Panapipat; Sue J Lee; Nicholas P J Day; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

10.  Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.

Authors:  Jin Li; Tamara Casteels; Thomas Frogne; Camilla Ingvorsen; Christian Honoré; Monica Courtney; Kilian V M Huber; Nicole Schmitner; Robin A Kimmel; Roman A Romanov; Caterina Sturtzel; Charles-Hugues Lardeau; Johanna Klughammer; Matthias Farlik; Sara Sdelci; Andhira Vieira; Fabio Avolio; François Briand; Igor Baburin; Peter Májek; Florian M Pauler; Thomas Penz; Alexey Stukalov; Manuela Gridling; Katja Parapatics; Charlotte Barbieux; Ekaterine Berishvili; Andreas Spittler; Jacques Colinge; Keiryn L Bennett; Steffen Hering; Thierry Sulpice; Christoph Bock; Martin Distel; Tibor Harkany; Dirk Meyer; Giulio Superti-Furga; Patrick Collombat; Jacob Hecksher-Sørensen; Stefan Kubicek
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.